Does Gleason score at initial diagnosis predict efficacy of abiraterone acetate therapy in patients with metastatic castration-resistant prostate cancer? An analysis of abiraterone acetate phase III trials
Fizazi, K., Flaig, T. W., Stöckle, M., Scher, H. I., de Bono, J. S., Rathkopf, D. E., Ryan, C. J., Kheoh, T., Li, J., Todd, M. B., Griffin, T. W., Molina, A., Ohlmann, C. H.Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv545
Date:
November, 2015
File:
PDF, 326 KB
english, 2015
File converter
More search results
More benefits 
